Westfield Capital Management
FMTX

Westfield Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Westfield Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,250
Closed -$361K – 270
2020
Q3 		$361K Buy
+7,250
New +$293K ﹤0.01% 232

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management's FMTX Position: Q4 2020 in Review

Westfield Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2020, closing a stake of 7,250 shares — an estimated $361K sold.

Westfield Capital Management first reported a position in FMTX in Q3 2020 and held it in 1 quarter. The position peaked at $361K in Q3 2020. 93 funds tracked by Wall St. Rank hold FMTX as of Q4 2020.

  • Westfield Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Westfield Capital Management sold 7,250 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2020, an estimated $361K.
  • Westfield Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Westfield Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $361K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2020.

Based on Westfield Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.